HolderBook

CASI PHARMACEUTICALS INC (CASI)

Institutional ownership reported to the SEC as of Q4 2022, across 17 quarters.

15
Reporting holders
$3.1M
Reported value
0.0%
Held as options
-3
Holder change

Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.

Holders

FilerValueShares Their book Held Change
FEDERATED HERMES, INC.$1.6M900,6510.00%3q-11.3%-$200.1K
VANGUARD GROUP INC$461.1K257,6180.00%3qHELD
Wellington Shields Capital Management, LLC$369.0K206,1480.04%17q-5.5%-$21.7K
Wellington Shields & Co., LLC$260.1K145,3150.06%13qHELD
BlackRock Inc.$164.2K91,7150.00%3qHELD
SUSQUEHANNA INTERNATIONAL GROUP, LLP$100.4K57,3950.00%2q+70.6%+$41.6K
STATE STREET CORP$62.2K35,5550.00%3qHELD
NORTHERN TRUST CORP$45.8K25,5930.00%3qHELD
FRANKLIN RESOURCES INC$43.0K24,5460.00%3qHELD
MORGAN STANLEY$3.5K1,9460.00%3q-48.7%-$3.3K
UBS Group AG$2.5K1,4230.00%2q-53.9%-$3.0K
GEODE CAPITAL MANAGEMENT, LLC$17198,1330.00%3qHELD
WELLS FARGO & COMPANY/MN$111620.00%newNEW
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$23130.00%newNEW
BANK OF AMERICA CORP /DE/$21120.00%newNEW
DIMENSIONAL FUND ADVISORS LP$2111,5080.00%3qHELD
RENAISSANCE TECHNOLOGIES LLC$2010,9000.00%2q+4.8%
Colonial Trust Co / SC$20110.00%newNEW
Tower Research Capital LLC (TRC)$73,4940.00%3q+59.8%
IFP Advisors, Inc$190.00%2qHELD

Quarter by quarter

Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.

QuarterHoldersValue SharesNewAdded TrimmedOptions
Q4 202215$3.1M1,748,0034140.0%
Q3 202218$5.2M1,987,6735440.0%
Q2 202218$6.3M2,187,86716020.0%
Q1 202239$18.9M23,324,04745130.0%
Q4 202147$22.8M28,497,09099130.0%
Q3 202156$46.0M38,674,7181011180.0%
Q2 202165$72.3M46,671,6431613240.0%
Q1 202181$127.6M53,158,0111629160.0%
Q4 202069$122.2M41,438,024929150.0%
Q3 202064$60.6M39,600,3051322150.0%
Q2 202056$57.2M22,878,891624130.0%
Q1 202055$44.4M21,747,733919160.0%
Q4 201951$65.3M21,120,952418120.0%
Q3 201950$36.4M10,895,276616110.0%
Q2 201948$37.4M11,694,85151780.0%
Q1 201951$33.0M11,491,346912150.0%
Q4 201850$48.3M12,003,4561120.0%